This essay is part of a First Opinion series on the future of the National Institutes of Health and American science.
Around the world, nations with robust research and development infrastructure race to create therapeutics that meet the needs of their residents. Simply put, they dictate research priorities based on need. During the Covid pandemic, the United States was one of the first countries to gain access to vaccines to protect its citizens.
STAT Pharma: The science and business of new drug development
Leave a Reply